Dear Reader,

Ever heard of Rhythm Biosciences [ASX:RHY]?

Back in May 2020, it was a tiny 8-cent ASX stock with an innovative cancer-detecting technology.

If you’d bought shares back then, you’d be looking at a 1,548% gain on your investment (at the time of writing).

The amazing part is this rapid growth happened during the pandemic.

Rhythm Biosciences is the perfect example of what I call a ‘wealth accelerator’.

Small, unknown firms pursuing big, disruptive ideas…

…with the potential to generate life-changing wealth regardless of what’s happening in the wider economy. They can be risky and won’t all shoot up like Rhythm Biosciences.

But recently, I have uncovered seven ‘wealth accelerator’ stocks that I believe have similar growth potential in 2022.

If it stings that you missed out on Rhythm Biosciences…

This might be your chance.

Read my report here.

Sincerely,

Murray Dawes,
Investment Director, Australian Small-Cap Investigator